Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 28, 2017; 23(32): 5969-5976
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5969
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5969
Table 2 Adverse events reported
| Event | Patients | |
| Any adverse event leading to discontinuation | - | 0 |
| Serious adverse events | Gastrointestinal bleeding/Portal vein thrombosis and Streptococcus bacteremia/Sinus bradycardia and first degree A-V block with syncope | 0 |
| Common adverse events | Fatigue | 2 |
| Diarrhea | 1 | |
| Tinnitus | 1 | |
| Elevation in serum creatinine | 2 | |
| Discomfort of abdomen | 1 | |
| Discomfort of transplanted kidney region | 1 | |
| Unstable blood pressure | 3 | |
| Rash | 0 | |
| Insomnia | 0 | |
| Headache | 0 |
- Citation: Xue Y, Zhang LX, Wang L, Li T, Qu YD, Liu F. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection. World J Gastroenterol 2017; 23(32): 5969-5976
- URL: https://www.wjgnet.com/1007-9327/full/v23/i32/5969.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i32.5969